What disease does Mitotane treat?

Mitotane (Mitotane) is a drug used to treat adrenocortical cancer (Adrenocortical Carcinoma ). Adrenocortical cancer is a rare but serious cancer that originates in cells of the outer cortex of the adrenal glands, often due to mutations in the cells. This cancer causes the adrenal cortex to produce too many hormones, such as cortisol, and the cancer cells may spread to other areas, complicating treatment.

Mitotane is used as a first-line treatment for adrenocortical cancer. Its mechanism of action includes inhibiting the ability of adrenocortical cells to produce hormones and directly damaging adrenocortical cells, thereby inhibiting the growth and spread of cancer cells. This makes mitotane one of the important drugs for the control of adrenocortical cancer.

The goals of treating adrenocortical cancer are to prolong survival, reduce symptoms, control cancer progression, and improve quality of life. Mitotan (mitotane) As a drug that inhibits tumor growth, it can achieve these goals to a certain extent.

Patients usually receive Mitotane treatment under the guidance of a professional doctor. During treatment, the patient's liver function and adrenocortical hormone levels need to be monitored regularly to ensure the effectiveness and safety of the drug. In addition, Mitotane may cause some side effects, such as digestive system problems, fatigue, skin reactions, etc. Therefore, it is necessary to pay close attention to the patient's reaction during treatment and deal with possible adverse reactions in a timely manner.

Overall,mitotaneis an effective drug for the treatment of adrenocortical cancer that can help control the progression of the cancer and improve patients' survival and quality of life. However, when using mitotane to treat adrenocortical cancer, it needs to be done under the guidance of a professional doctor and monitored and evaluated regularly to ensure the effectiveness and safety of the treatment.